Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Kathleen M S E. Reyskens »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Kathleen Kahn < Kathleen M S E. Reyskens < Kathleen M. Defilippi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000833 (2014) Kathleen M S E. Reyskens [Afrique du Sud] ; M Faadiel Essop [Afrique du Sud]HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system.
000927 (2013) Kathleen M S E. Reyskens [Afrique du Sud] ; M Faadiel EssopThe maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart.
000B37 (2013) Kathleen M S E. Reyskens [Afrique du Sud] ; Tarryn-Lee Fisher ; Jonathan C. Schisler ; Wendi G. O'Connor ; Arlin B. Rogers ; Monte S. Willis ; Cynthia Planesse ; Florence Boyer ; Philippe Rondeau ; Emmanuel Bourdon ; M Faadiel EssopCardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Animals
2HIV Infections (drug therapy)
2HIV Protease Inhibitors (adverse effects)
2Male
2Oxidative Stress (drug effects)
2Rats
2Rats, Wistar
1Adaptation, Physiological (drug effects)
1Analysis of Variance
1Antiretroviral Therapy, Highly Active (methods)
1Blotting, Western
1Calcineurin (metabolism)
1Calcium-Binding Proteins (metabolism)
1Cardiovascular Diseases (chemically induced)
1Cardiovascular Diseases (complications)
1Cardiovascular Diseases (metabolism)
1Cholesterol, LDL (blood)
1Connexin 43 (metabolism)
1DNA Primers (genetics)
1Drug Combinations
1Gene Expression Regulation, Enzymologic (drug effects)
1HIV Infections (complications)
1HIV Infections (metabolism)
1HIV Protease Inhibitors (pharmacology)
1HIV Protease Inhibitors (therapeutic use)
1Heart (drug effects)
1Heart (physiopathology)
1Humans
1In Vitro Techniques
1Liver (metabolism)
1Lopinavir (adverse effects)
1Lopinavir (pharmacology)
1Models, Biological
1Myocardium (metabolism)
1NFATC Transcription Factors (metabolism)
1Proteasome Endopeptidase Complex (drug effects)
1Proteasome Endopeptidase Complex (metabolism)
1Reactive Oxygen Species (metabolism)
1Real-Time Polymerase Chain Reaction
1Risk Factors
1Ritonavir (adverse effects)
1Ritonavir (pharmacology)
1Triglycerides (metabolism)
1Ubiquitin (metabolism)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Kathleen M S E. Reyskens" 
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Kathleen M S E. Reyskens" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Kathleen M S E. Reyskens
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024